Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2...

|About: Array BioPharma Inc. (ARRY)|By:, SA News Editor

Array BioPharma (ARRY +2.4%) trades up after announcing positive results from Phase 1 and 2 testing of its kinesin spindle protein inhibitor, ARRY-520, yesterday at the annual meeting of the American Society of Hematology in San Diego, California.